Transcranial magnetic stimulation in the treatment of substance addiction

Annals of the New York Academy of Sciences

Volumn 1327, Issue 1, 2014, Pages 79-93

  Gorelick, David A ^a,b   Zangen, Abraham ^c   George, Mark S ^d,e  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Addiction; Substance use disorder; TMS; Transcranial magnetic stimulation; Treatment

Indexed keywords

ADULT; ALCOHOLISM; ARTICLE; COCAINE DEPENDENCE; FREQUENCY MODULATION; HUMAN; MAJOR CLINICAL STUDY; METHAMPHETAMINE DEPENDENCE; NEUROMODULATION; PATIENT SAFETY; PREFRONTAL CORTEX; PULSE RATE; SELECTIVE ATTENTION; SHAM PROCEDURE; SMOKING; SUBSTANCE ABUSE; THERAPY EFFECT; TOBACCO DEPENDENCE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION; WITHDRAWAL SYNDROME; ANIMAL; BRAIN LEVEL; EVIDENCE BASED MEDICINE; INHIBITION (PSYCHOLOGY); METABOLISM; NERVE CELL; SUBSTANCE-RELATED DISORDERS;

ANIMALS; BRAIN CHEMISTRY; EVIDENCE-BASED MEDICINE; HUMANS; INHIBITION (PSYCHOLOGY); NEURONS; PREFRONTAL CORTEX; SUBSTANCE-RELATED DISORDERS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84915735600     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12479     Document Type: Article

References (107)

1. Kluger, B.M. & W.J. Triggs. 2007. Use of transcranial magnetic stimulation to influence behavior. Curr. Neurol. Neurosci. Rep. 7: 491-497.
2. Rossini, P.M. & S. Rossi. 2007. Transcranial magnetic stimulation: diagnostic, therapeutic, and research potential. Neurology 68: 484-488.
3. Speer, A.M., T.A. Kimbrell, E.M. Wassermann, et al. 2000. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol. Psychiatry 48: 1133-1141.
4. Ziemann, U., W. Paulus, M.A. Nitsche, et al. 2008. Consensus: motor cortex plasticity protocols. Brain Stimul. 1: 164-182.
5. Nahas, Z., C.C. Teneback, A. Kozel, et al. 2001. Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance. J. Neuropsychiatr. Clin. Neurosci. 13: 459-470.
6. Eldaief, M.C., M.A. Halko, R.L. Buckner & A. Pascual-Leone. 2011. Transcranial magnetic stimulation modulates the brain's intrinsic activity in a frequency-dependent manner. Proc. Natl. Acad. Sci. U. S. A. 108: 21229-21234.
7. Bestmann, S., C.C. Ruff, F. Blankenburg, et al. 2008. Mapping causal interregional influences with concurrent TMS-fMRI. Exp. Brain Res. 191: 383-402.
8. Denslow, S., M. Lomarev, M.S. George & D.E. Bohning. 2005. Cortical and subcortical brain effects of transcranial magnetic stimulation (TMS)-induced movement: an interleaved TMS/functional magnetic resonance imaging study. Biol. Psychiatry 57: 752-760.
9. Li, X., Z. Nahas, F.A. Kozel, et al. 2004. Acute left prefrontal transcranial magnetic stimulation in depressed patients is associated with immediately increased activity in prefrontal cortical as well as subcortical regions. Biol. Psychiatry 55: 882-890.
10. Paus, T., M.A. Castro-Alamancos & M. Petrides. 2001. Cortico-cortical connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation. Eur. J. Neurosc. 14: 1405-1411.
11. Speer, A.M., M.W. Willis, P. Herscovitch, et al. 2003. Intensity-dependent regional cerebral blood flow during 1-Hz repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers studied with H215O positron emission tomography: II. Effects of prefrontal cortex rTMS. Biol. Psychiatry 54: 826-832.
12. Cho, S.S. & A.P. Strafella. 2009. rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PloS One 4: e6725.
13. Taylor, J.J., J.J. Borckardt, M. Canterberry, et al. 2013. Naloxone-reversible modulation of pain circuitry by left prefrontal rTMS. Neuropsychopharmacology 38: 1189-1197.
14. Fitzgerald, P.B. 2011. The emerging use of brain stimulation treatments for psychiatric disorders. Aust. N. Z. J. Psychiatry 45: 923-938.
15. Kammer, T. & M. Spitzer. 2012. Brain stimulation in psychiatry: methods and magnets, patients and parameters. Curr. Opin. Psychiatry 25: 535-541.
16. Bellamoli, E., P. Manganotti, R.P. Schwartz, et al. 2014. rTMS in the treatment of drug addiction: an update about human studies. Behav. Neurol.
17. Jansen, J.M., J.G. Daams, M.W. Koeter, et al. 2013. Effects of non-invasive neurostimulation on craving: a meta-analysis. Neurosci. Biobehav. Rev. 37: 2472-2480.
18. Dinur-Klein, L., P. Dannon, A. Hadar, et al. 2014. Smoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: a prospective, randomized controlled trial. Biol. Psychiatry. Published online 6/4/14. DOI: http://dx.doi.org/10.1016/j.biopsych.2014.05.020.
19. Ribeiro, P.L., D. Arnaut, M.L. Mincovicks, H.D. Marra, et al. 2013. Controlled clinical trial of rTMS for treatment of cocaine addiction. In Proceedings of the 11th World Congress of Biological Psychiatry, Kyoto, Japan.
20. Hayashi, T., J.H. Ko, A.P. Strafella & A. Dagher. 2013. Dorsolateral prefrontal and orbitofrontal cortex interactions during self-control of cigarette craving. Proc. Natl. Acad. Sci. U. S. A. 110: 4422-4427.
21. Johann, M., R. Wiegand, A. Kharraz, et al. 2003. Transcranial magnetic stimulation for nicotine dependence. Psychiatrische Praxis 30(Suppl. 2): S129-S131.
22. Li, X., K.J. Hartwell, M. Owens, et al. 2013. Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex reduces nicotine cue craving. Biol. Psychiatry 73: 714-720.
23. Eichhammer, P., M. Johann, A. Kharraz, et al. 2003. High-frequency repetitive transcranial magnetic stimulation decreases cigarette smoking. J. Clin. Psychiatry 64: 951-953.
24. Amiaz, R., D. Levy, D. Vainiger, et al. 2009. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction 104: 653-660.
25. Gorelick, D.A., H.H. Holcomb, D.L. Boggs, et al. 2013. fMRI-guided TMS to disrupt cue-associated craving as treatment for nicotine addiction. In Proceedings of the 11th World Congress of Biological Psychiatry, Kyoto, Japan.
26. Wing, V.C., I. Bacher, B.S. Wu, et al. 2012. High frequency repetitive transcranial magnetic stimulation reduces tobacco craving in schizophrenia. Schizophr. Res. 139: 264-266.
27. Li, X., R.J. Malcolm, K. Huebner, et al. 2013. Low frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex transiently increases cue-induced craving for methamphetamine: A preliminary study. Drug Alcohol Depend. 133: 641-646.
28. Camprodon, J.A., J. Martinez-Raga, M. Alonso-Alonso, et al. 2007. One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving. Drug Alcohol Depend. 86: 91-94.
29. Politi, E., E. Fauci, A. Santoro & E. Smeraldi. 2008. Daily sessions of transcranial magnetic stimulation to the left prefrontal cortex gradually reduce cocaine craving. Am. J. Addict. 17: 345-346.
30. Herremans, S.C., C. Baeken, N. Vanderbruggen, et al. 2012. No influence of one right-sided prefrontal HF-rTMS session on alcohol craving in recently detoxified alcohol-dependent patients: results of a naturalistic study. Drug Alcohol Depend. 120: 209-213.
31. Herremans, S.C., M.A. Vanderhasselt, R. De Raedt & C. Baeken. 2013. Reduced intra-individual reaction time variability during a Go-NoGo task in detoxified alcohol-dependent patients after one right-sided dorsolateral prefrontal HF-rTMS session. Alcohol Alcohol. 48: 552-557.
32. Mishra, B.R., S.H. Nizamie, B. Das & S.K. Praharaj. 2010. Efficacy of repetitive transcranial magnetic stimulation in alcohol dependence: a sham-controlled study. Addiction 105: 49-55.
33. Hoppner, J., T. Broese, L. Wendler, et al. 2011. Repetitive transcranial magnetic stimulation (rTMS) for treatment of alcohol dependence. World J. Biol. Psychiatry 12(Suppl. 1): 57-62.
34. De Ridder, D., S. Vanneste, S. Kovacs, et al. 2011. Transient alcohol craving suppression by rTMS of dorsal anterior cingulate: an fMRI and LORETA EEG study. Neurosci. Lett. 496: 5-10.
35. Rapinesi, C., G.D. Kotzalidis, D. Serata, et al. 2013. Efficacy of add-on deep transcranial magnetic stimulation in comorbid alcohol dependence and dysthymic disorder: three case reports. Prim. Care Companion CNS Disord. 15: PCC.12m01438.
36. Sampaio, L.A., R. Fraguas, P.A. Lotufo, et al. 2012. A systematic review of non-invasive brain stimulation therapies and cardiovascular risk: implications for the treatment of major depressive disorder. Front. Psychiatry 3: 87.
37. Rossi, S, M. Hallett, P.M. Rossini & A. Pascual-Leone. 2009. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin. Neurophysiol. 120: 2008-2039.
38. Barr, M.S., P.B. Fitzgerald, F. Farzan, et al. 2008. Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders. Curr. Drug Abuse Rev. 1: 328-339.
39. Brust, J.C. 2008. Seizures, illicit drugs, and ethanol. Curr. Neurol. Neurosci. Rep. 8: 333-338.
40. Boutros, N.N., S.H. Lisanby, H. Tokuno, et al. 2001. Elevated motor threshold in drug-free, cocaine-dependent patients assessed with transcranial magnetic stimulation. Biol. Psychiatry 49: 369-373.
41. Boutros, N.N., S.H. Lisanby, D. McClain-Furmanski, et al. 2005. Cortical excitability in cocaine-dependent patients: a replication and extension of TMS findings. J. Psychiatr. Res. 39: 295-302.
42. Sundaresan, K., U. Ziemann, J. Stanley & N. Boutros. 2007. Cortical inhibition and excitation in abstinent cocaine-dependent patients: a transcranial magnetic stimulation study. Neuroreport 18: 289-292.
43. Gjini, K., U. Ziemann, T.C. Napier & N. Boutros. 2012. Dysbalance of cortical inhibition and excitation in abstinent cocaine-dependent patients. J. Psychiatr. Res. 46: 248-255.
44. Aleman, A. 2013. Use of repetitive transcranial magnetic stimulation for treatment in psychiatry. Clin. Psychopharmacol. neurosci. 11: 53-59.
45. Hovington, C.L., A. McGirr, M. Lepage & M.T. Berlim. 2013. Repetitive transcranial magnetic stimulation (rTMS) for treating major depression and schizophrenia: a systematic review of recent meta-analyses. Ann. Med. 45: 308-321.
46. Rose, J.E., F.J. McClernon, B. Froeliger, et al. 2011. Repetitive transcranial magnetic stimulation of the superior frontal gyrus modulates craving for cigarettes. Biol. Psychiatry 70: 794-799.
47. Gorelick, D., H.H. Holcomb, D.L. Boggs, et al. 2013. Individual differences in fMRI cortical BOLD responses to nicotine visual cues in dependent cigarette smokers. Biol. Psychiatry 73: 326S.
48. Hanlon, C.A., E.M. Jones, X. Li, et al. 2012. Individual variability in the locus of prefrontal craving for nicotine: implications for brain stimulation studies and treatments. Drug Alcohol Depend. 125: 239-243.
49. Beauchamp, M.S., A.R. Nath & S. Pasalar. 2010. fMRI-Guided transcranial magnetic stimulation reveals that the superior temporal sulcus is a cortical locus of the McGurk effect. J. Neurosci. 30: 2414-2417.
50. Feredoes, E., G. Tononi & B.R. Postle. 2007. The neural bases of the short-term storage of verbal information are anatomically variable across individuals. J. Neurosci. 27: 11003-11008.
51. Sack, A.T., R. Cohen Kadosh, T. Schuhmann, et al. 2009. Optimizing functional accuracy of TMS in cognitive studies: a comparison of methods. J. Cogn. Neurosci. 21: 207-221.
52. Li, X., C.H. Large, R. Ricci, et al. 2011. Using interleaved transcranial magnetic stimulation/functional magnetic resonance imaging (fMRI) and dynamic causal modeling to understand the discrete circuit specific changes of medications: lamotrigine and valproic acid changes in motor or prefrontal effective connectivity. Psychiatry Res. 194: 141-148.
53. Li, X., R. Ricci, C.H. Large, et al. 2010. Interleaved transcranial magnetic stimulation and fMRI suggests that lamotrigine and valproic acid have different effects on corticolimbic activity. Psychopharmacology 209: 233-244.
54. Li, X., C.C. Teneback, Z. Nahas, et al. 2004. Interleaved transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men. Neuropsychopharmacology 29: 1395-1407.
55. Peleman, K., P. Van Schuerbeek, R. Luypaert, et al. 2010. Using 3D-MRI to localize the dorsolateral prefrontal cortex in TMS research. World J. Biol. Psychiatry 11: 425-430.
56. Toro, R., M. Perron, B. Pike, et al. 2008. Brain size and folding of the human cerebral cortex. Cereb. Cortex 18: 2352-2357.
57. Mylius, V., S.S. Ayache, R. Ahdab, et al. 2013. Definition of DLPFC and M1 according to anatomical landmarks for navigated brain stimulation: inter-rater reliability, accuracy, and influence of gender and age. NeuroImage 78: 224-232.
58. Ahdab, R., S.S. Ayache, P. Brugieres, et al. 2010. Comparison of "standard" and "navigated" procedures of TMS coil positioning over motor, premotor and prefrontal targets in patients with chronic pain and depression. Neurophysiol. Clin. 40: 27-36.
59. Fitzgerald, P.B., J.J. Maller, K.E. Hoy, et al. 2009. Exploring the optimal site for the localization of dorsolateral prefrontal cortex in brain stimulation experiments. Brain Stimul. 2: 234-237.
60. Nauczyciel, C., P. Hellier, X. Morandi, et al. 2011. Assessment of standard coil positioning in transcranial magnetic stimulation in depression. Psychiatry Res. 186: 232-238.
61. Rusjan, P.M., M.S. Barr, F. Farzan, et al. 2010. Optimal transcranial magnetic stimulation coil placement for targeting the dorsolateral prefrontal cortex using novel magnetic resonance image-guided neuronavigation. Hum. Brain Mapp. 31: 1643-1652.
62. Fitzgerald, P.B., K. Hoy, S. McQueen, et al. 2009. A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsychopharmacology 34: 1255-1262.
63. Langguth, B., T. Kleinjung, M. Landgrebe, et al. 2010. rTMS for the treatment of tinnitus: the role of neuronavigation for coil positioning. Neurophysiol. Clin. 40: 45-58.
64. Wu, S., T. Maloney, D.L. Gilbert, et al. 2014. Functional MRI-navigated repetitive transcranial magnetic stimulation over supplementary motor area in chronic tic disorders. Brain Stimul 7: 212-218.
65. Sparing, R., D. Buelte, I.G. Meister, et al. 2008. Transcranial magnetic stimulation and the challenge of coil placement: a comparison of conventional and stereotaxic neuronavigational strategies. Hum. Brain Mapp. 29: 82-96.
66. Bersani, F.S., A. Minichino, P.G. Enticott, et al. 2013. Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: a comprehensive review. Eur. Psychiatry 28: 30-39.
67. Roth, Y., G.S. Pell & A. Zangen. 2013. Commentary on: Deng et al., electric field depth-focality tradeoff in transcranial magnetic stimulation: simulation comparison of 50 coil designs. Brain Stimul. 6: 14-15.
68. Roth, Y., G.S. Pell, A.V. Chistyakov, et al. 2014. Motor cortex activation by H-coil and figure-8 coil at different depths. Combined motor threshold and electric field distribution study. Clin. Neurophysiol. 125: 336-343.
69. Hallett, M. 2000. Transcranial magnetic stimulation and the human brain. Nature 406: 147-150.
70. Lee, J.C., D.M. Blumberger, P.B. Fitzgerald, et al. 2012. The role of transcranial magnetic stimulation in treatment-resistant depression: a review. Curr. Pharm. Des. 18: 5846-5852.
71. Mantovani, A., M. Pavlicova, D. Avery, et al. 2012. Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression. Depress. Anxiety 29: 883-890.
72. McDonald, W.M., V. Durkalski, E.R. Ball, et al. 2011. Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress. Anxiety 28: 973-980.
73. Rosenberg, H. 2009. Clinical and laboratory assessment of the subjective experience of drug craving. Clin. Psychol. Rev. 29: 519-534.
74. Wilson, S.J., M.A. Sayette & J.A. Fiez. 2004. Prefrontal responses to drug cues: a neurocognitive analysis. Nat. Neurosci. 7: 211-214.
75. McBride, D., S.P. Barrett, J.T. Kelly, et al. 2006. Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: an fMRI study. Neuropsychopharmacology 31: 2728-2738.
76. Kaptchuk, T.J., P. Goldman, D.A. Stone & W.B. Stason. 2000. Do medical devices have enhanced placebo effects? J. Clin. Epidemiol. 53: 786-792.
77. Brunoni, A.R., M. Lopes, T.J. Kaptchuk & F. Fregni. 2009. Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis. PloS One 4: e4824.
78. Berlim, M.T., H.J. Broadbent & F. Van Den Eynde. 2013. Blinding integrity in randomized sham-controlled trials of repetitive transcranial magnetic stimulation for major depression: a systematic review and meta-analysis. Int. J. Neuropsychopharmacol. 16: 1173-1181.
79. Broadbent, H.J., F. Van Den Eynde, S. Guillaume, et al. 2011. Blinding success of rTMS applied to the dorsolateral prefrontal cortex in randomised sham-controlled trials: a systematic review. World J. Biol. Psychiatry 12: 240-248.
80. Borckardt, J.J., J. Walker, R.K. Branham, et al. 2008. Development and evaluation of a portable sham transcranial magnetic stimulation system. Brain Stimul. 1: 52-59.
81. Borckardt, J.J., Z.H. Nahas, J. Teal, et al. 2013. The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the double-blind phase of the OPT-TMS trial. Brain Stimul. 6: 925-928.
82. Hadley, D., B.S. Anderson, J.J. Borckardt, et al. 2011. Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. J. ECT 27: 18-25.
83. Berlim, M.T., F. Van Den Eynde, Z.J. Daskalakis. 2013. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials. J. Clin. Psychiatry 74: e122-e129.
84. Ziemann, U., A. Tam, C. Butefisch & L.G. Cohen. 2002. Dual modulating effects of amphetamine on neuronal excitability and stimulation-induced plasticity in human motor cortex. Clin. Neurophysiol. 113: 1308-1315.
85. Buchmann, J., A. Dueck, W. Gierow, et al. 2010. Modulation of motorcortical excitability by methylphenidate in adult voluntary test persons performing a go/nogo task. J. Neural Transm. 117: 249-258.
86. Paulus, W., J. Classen, L.G. Cohen, et al. 2008. State of the art: pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation. Brain Stimul. 1: 151-163.
87. George, M.S., F. Padberg, T.E. Schlaepfer, et al. 2009. Controversy: repetitive transcranial magnetic stimulation or transcranial direct current stimulation shows efficacy in treating psychiatric diseases (depression, mania, schizophrenia, obsessive-complusive disorder, panic, posttraumatic stress disorder). Brain Stimul. 2: 14-21.
88. Diana, M. 2011. The dopamine hypothesis of drug addiction and its potential therapeutic value. Front. Psychiatry 2: 64.
89. Volkow, N.D., G.J. Wang, J.S. Fowler, et al. 2011. Addiction: beyond dopamine reward circuitry. Proc. Nat.l Acad. Sci. U. S. A. 108: 15037-15042.
90. Feil, J. & A. Zangen. 2010. Brain stimulation in the study and treatment of addiction. Neurosci. Biobehav. Rev. 34: 559-574.
91. Strafella, A.P., T. Paus, J. Barrett & A. Dagher. 2001. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J. Neurosci. 21: RC157.
92. Keck, M.E., T. Welt, M.B. Muller, et al. 2002. Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology 43: 101-109.
93. Kanno, M., M. Matsumoto, H. Togashi, et al. 2004. Effects of acute repetitive transcranial magnetic stimulation on dopamine release in the rat dorsolateral striatum. J. Neurol. Sci. 217: 73-81.
94. Zangen, A. & K. Hyodo. 2002. Transcranial magnetic stimulation induces increases in extracellular levels of dopamine and glutamate in the nucleus accumbens. Neuroreport 13: 2401-2405.
95. Erhardt, A., I. Sillaber, T. Welt, et al. 2004. Repetitive transcranial magnetic stimulation increases the release of dopamine in the nucleus accumbens shell of morphine-sensitized rats during abstinence. Neuropsychopharmacology 29: 2074-2080.
96. Javitt, D.C., D. Schoepp, P.W. Kalivas, et al. 2011. Translating glutamate: from pathophysiology to treatment. Sci. Transl. Med. 3: 102mr2.
97. Quintero, G.C. 2013. Role of nucleus accumbens glutamatergic plasticity in drug addiction. Neuropsychiatr. Dis. Treat. 9: 1499-1512.
98. Gersner, R., E. Kravetz, J. Feil, et al. 2011. Long-term effects of repetitive transcranial magnetic stimulation on markers for neuroplasticity: differential outcomes in anesthetized and awake animals. J. Neurosci. 31: 7521-7526.
99. Levy, D., M. Shabat-Simon, U. Shalev, et al. 2007. Repeated electrical stimulation of reward-related brain regions affects cocaine but not "natural" reinforcement. J. Neurosci. 27: 14179-14189.
100. Guse, B., P. Falkai & T. Wobrock. 2010. Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review. J. Neural Transm. 117: 105-122.
101. Fecteau, S., F. Fregni, P.S. Boggio, et al. 2010. Neuromodulation of decision-making in the addictive brain. Subst. Use Misuse 45: 1766-1786.
102. Feil, J., D. Sheppard, P.B. Fitzgerald, et al. 2010. Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control. Neurosci. Biobehav. Rev. 35: 248-275.
103. Perry, J.L., J.E. Joseph, Y. Jiang, et al. 2011. Prefrontal cortex and drug abuse vulnerability: translation to prevention and treatment interventions. Brain Res. Rev. 65: 124-149.
104. Taylor, J.J., J.J. Borckardt & M.S. George. 2012. Endogenous opioids mediate left dorsolateral prefrontal cortex rTMS-induced analgesia. Pain 153: 1219-1225.
105. Martin, L., J.J. Borckardt, S.T. Reeves, et al. 2013. A pilot functional MRI study of the effects of prefrontal rTMS on pain perception. Pain Med. 14: 999-1009.
106. George, O. & G.F. Koob. 2013. Control of craving by the prefrontal cortex. Proc. Natl. Acad. Sci. U. S. A. 110: 4165-4166.
107. Garavan, H. 2010. Insula and drug cravings. Brain Struct. Funct. 214: 593-601.